 Swiss Biotech company MPC Therapeutics announces completion of its CHF 1.5M seed-funding round to improve CAR-T cancer therapies. Read Full Story at source may require registration The post MPC Therapeutics Announces Completion of Its CHF 1.5M Seed-Funding Round to Improve CAR-T Cancer Therapies. appeared first on ForexTV... 